A Study of LY3867070 in Healthy Participants
Phase 1
196
about 1.3 years
18–65
2 sites in CA, TX
What this study is about
This trial is testing a new medication called LY3867070 in healthy people. The goal is to see if the medication is safe and what side effects might occur. Blood tests will be done to understand how the body processes the medication.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take LY3867070
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of Participants with One or More Adverse Event(s) (AEs) Considered by the Investigator to be Related to Study Drug Administration, Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration, Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) Considered by the Investigator to be Related to Study Drug Administration
Secondary: PK: Maximum Concentration (Cmax) of LY3867070, Part B Pharmacodynamic (PD): Change from Baseline in Gene Expression, Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of LY3867070